It was reported that a patient underwent an atrial fibrillation (afib) ablation procedure with a thermocool® smart touch¿ bi-directional navigation catheter and the patient suffered pulmonary vein stenosis, mediastinal hematoma requiring prolonged hospitalization.Three (3) months after ablation of af by isolation of the pulmonary veins with a thermocool® smart touch¿ bi-directional navigation catheter, the patient was reviewed in a consultation and determined the patient had a persistent dry cough.The patient had a computed tomography (ct) scan showing mediastinal hematoma and probable stenosis of the left lower pulmonary vein.There was no post-op device malfunction.Additional information was later received indicating the afib ablation was in march, the adverse event was diagnosed on may 31st.The physician¿s opinion on the cause of this adverse event is that it was procedure related.The patient outcome of the adverse event is unchanged.The patient is going to be hospitalized for an endovascular procedure.
|
Device investigation details: available information received indicates that the device is not available for return, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.A manufacturing record evaluation (mre) cannot be conducted because a recognized lot number was not provided by the customer.This report is being submitted pursuant to the provisions of 21 cfr, part 4.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Initial reporter phone: (b)(6).Manufacturer's ref.# (b)(4).
|